• Belmore Banner Image

    Persuasive Advocacy.
    Proven Results.

    We are experts in intellectual property litigation. We are trial lawyers.
    We are appellate lawyers. We know patent law, inside and out.

    Learn More

News

Read More News

Our Team

Our cases

  • Janssen Inc. v Pharmascience Inc.

    Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
    Belmore Neidrauer secured another victory in the Federal Court of Appeal for our client Janssen relating to the validity of Janssen’s patent covering INVEGA SUSTENNA®
    Read more

  • Janssen Inc. v Apotex Inc.

    Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
    We successfully represented Janssen on another appeal relating to infringement of Janssen’s patent covering INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product for the treatment of schizophrenia.
    Read more

  • Janssen v. Pharmascience

    Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
    We successfully represented Janssen in the Federal Court of Appeal on this appeal relating to infringement of the patent covering Janssen’s INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product for the treatment of schizophrenia.
    Read more

  • Janssen Inc. v Apotex Inc.

    Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
    Belmore Neidrauer has successfully represented Janssen on another appeal, resulting in a decision overturning the Federal Court’s denial of summary judgment.
    Read more

  • Janssen Inc. et al v. Teva Canada Limited

    Counsel: Marian Wolanski and Megan Pocalyuko
    We successfully represented Janssen on Teva’s appeal and Janssen’s cross-appeal in a significant decision relating to the law of inducing patent infringement in Canada. The decision relates to Janssen’s patent covering INVEGA SUSTENNA® (paliperidone ...
    Read more

  • Janssen v. Apotex

    Counsel: Stephanie Anderson
    We successfully represented Janssen in a motion to appeal an order of the Associate Judge which declined, based on relevance, to compel Apotex to answer certain discovery questions related to its ability to supply its generic abiraterone acetate prod...
    Read more

  • Janssen v. Apotex

    Counsel: Stephanie Anderson
    We successfully represented Janssen in a motion to Amend its Statement of Defence in this PMNOC section 8 damages action. The Court agreed that Janssen was allowed to amend its Statement of Defence to raise issues as to Apotex’s ability to supply the...
    Read more

  • Janssen v. Dr. Reddy

    Counsel: Stephanie Anderson
    We successfully represented Janssen in this motion brought by Dr. Reddy’s in the context of a PMNOC section 8 damages action. Dr. Reddy’s was seeking to have a question of law determined before trial. The question of law related to whether Janssen co...
    Read more

  • Janssen v. Pharmascience

    Counsel: Marian Wolanski
    We successfully represented Janssen in a motion brought by the appellant (Pharmascience) to settle the contents of the appeal book in the context of an appeal from the judgment of the Federal Court in Janssen Inc. v. Pharmascience Inc., 2022 FC 1218 ...
    Read more

  • Alexion v. Attorney General of Canada

    Counsel: Marian Wolanski
    This was an application to add an inventor to two patents owned by Alexion Pharmaceuticals. The patents relate to Alexion’s blockbuster drug SOLIRIS. The application was granted, ensuring that the correct inventors are named on the patents relating t...
    Read more

  • Apotex Inc. v Janssen Inc. et al

    Counsel: Stephanie Anderson and Heather Lindsay
    We successfully represented Janssen on these motions seeking non-party discovery in three PMNOC section 8 actions.Each of Apotex, Dr. Reddy’s and Pharmascience resisted, on numerous grounds, non-party discovery for use in these section 8 actions. The...
    Read more

  • Janssen v. Pharmascience

    Counsel: Marian Wolanski, Megan Pocalyuko and Oleyna Strigul
    We successfully represented Janssen in defending the validity of the patent relating to Janssen’s INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product used to treat schizophrenia.
    Read more

  • Janssen v Apotex

    Counsel: Marian Wolanski and Megan Pocalyuko
    We successfully represented Janssen in this summary trial in the Federal Court on infringement issues against Apotex in respect of Janssen’s patent covering its important INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product used t...
    Read more

  • Janssen v Pharmascience

    Counsel: Marian Wolanski and Megan Pocalyuko
    We successfully represented Janssen in this summary trial in the Federal Court on infringement issues against Pharmascience in respect of Janssen’s patent covering its important INVEGA SUSTENNA® (paliperidone palmitate) once-monthly injection product...
    Read more

  • Janssen v Apotex, Pharmascience and Dr. Reddy’s Laboratories

    Counsel: Marian Wolanski, Stephanie Anderson and Megan Pocalyuko
    We represented Janssen and BTG in these patent infringement actions relating to Janssen’s prostate cancer product ZYTIGA®(abiraterone acetate). We were successful in proving inducing infringement and in resisting the defendants’ attacks based on lack...
    Read more

  • Seedlings v. Pfizer

    Counsel: Stephanie Anderson
    We successfully represented Pfizer on this appeal related to a mechanical device patent and Pfizer’s epinephrine auto injector product EpiPen®. The Federal Court of Appeal upheld the trial judge’s decision on claim construction, anticipation, obvious...
    Read more

  • Eli Lilly Canada Inc. et al v. Apotex Inc.

    Counsel: Marian Wolanski
    We represented Eli Lilly, Daiichi and Ube in this application relating to a patent covering Eli Lilly’s EFFIENT product.
    Read more

  • Apotex v. Janssen

    Counsel: Stephanie Anderson
    We successfully represented Janssen on this appeal. The Federal Court of Appeal upheld the trial judge’s decision that the patent was valid and infringed. On validity, the Court clarified the nature of evidence that can be used to establish demonstra...
    Read more

  • Elea v Simplot

    We successfully represented Elea on this appeal. J.R Simplot, the defendant in a patent infringement action brought by McCain, had issued a third party claim against Elea, alleging that Elea was responsible for any damages that Simplot may be require...
    Read more

  • Seedlings Life Sciences v Pfizer

    Counsel: Marian Wolanski
    We successfully represented Pfizer in this patent infringement action. Seedlings – a non-practicing entity – alleged that Pfizer’s EpiPen infringed a Seedlings patent. Seedlings was seeking all of the profits earned by Pfizer on EpiPen sales since 20...
    Read more
See all cases

Awards

Consistently Recognized
for Excellence.

We are consistently recognized as leading IP litigators in Canada. Among others, we are recognized by:
  • IAM Patent 1000 Recognized for Patent Litigation 2025
  • Legal 500 Canada Elite Boutique 2025
  • Best Law Firms - Canada Tier 1 for Intellectual Property Law 2025
  • Chambers Recognized for Intellectual Property: Litigation 2025
  • IAM Patent 1000 Recognized for Patent Litigation 2024
  • Chambers Recognized for Intellectual Property: Litigation 2024
  • Legal 500 Canada Elite Boutique 2024
  • LMG Life Science Patent Impact Case of the Year: Teva v. Janssen (2023 FCA 68) 2023
See all awards